Verinomics
Genomics & Genetic Testing · Biotechnology
$4.8Mtotal raised · 4 rounds on record
$2.7Mlatest round · Venture round · Sep 2026 · 2 mo ago
1backers · Cleveland Avenue
$557kgrants · 2 grants · CORDIS
Overview
Verinomics combines cutting-edge trait discovery with precision breeding and gene editing, delivering scalable, customizable solutions tailored for specialty crops.
Key facts
These are the key facts about Verinomics on Alion as of Nov 13, 2026. Verinomics is headquartered in New Haven, United States. It was founded in 2016. It has raised $4.8M in 2 funding rounds. The latest round is Venture - Series Unknown of $2.7M, announced in 2026.
- Headquarters
- New Haven, United StatesAlion company profile, updated Oct 11, 2026
- Founded
- 2016Alion company profile, updated Oct 11, 2026
- Employees
- 10+Alion company profile, an estimated range
- Total raised
- $4.8MSum of 2 equity rounds Alion knows
- Latest round
- Venture - Series Unknown · $2.7M · Sep 9, 2026SEC Form D filing · sec.gov
Official records
Funding and backers
Total raised
$4.8M
4 rounds on record
Latest round
$2.7M
Venture round · Sep 2026 · 2 mo ago
Team
17
US Form 5500 (plan participants) · Dec 2025 · +13% in a year
Grants
$557k
2 grants · CORDIS
Backers
1
Cleveland Avenue
The money's age
Fresh money
2 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 9
Raised a round Venture round $2.7M · SEC Form D
May 8, 2025
Partnership Verinomics and Pinnacle Seed Form Strategic Partnership to Accelerate Innovation in Leafy Greens · uk.finance.yahoo.com
Mar 10, 2025
Launched Verinomics Introduces Transgene-Free Gene Editing and Genomic-Driven Accelerated Breeding Platforms for Specialty Crops · businesswire.com
Dec 20, 2024
Won a grant $307k · CORDIS
Feb 12, 2024
Won a grant $250k · CORDIS
Dec 21, 2018
Raised a round Venture round $2M · SEC Form D
2016
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Sep 2026 | $2.7M | — | SEC Form D |
| Grant | Dec 2024 | $307k | — | CORDIS |
| Grant | Feb 2024 | $250k | — | CORDIS |
| Venture round | Dec 2018 | $2M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Verinomics, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Stephen DellaportaExecutive Officer, DirectorSEC Form D
Christopher HeffelfingerExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Unlock the future with biotechnology! Paint with bacteria, make agar art, and create bioplastics. Engineer bacteria to glow, change color…
Tap Into The Power of Your DNA. Unlock the hidden potential in your DNA and gain personalized insights to transform your well-being. Dive…
Tropic transforms agriculture with cutting-edge genetic innovation. Together, we're building a productive and sustainable future for…
Detect Early, Live Fully. Our mission at OrisDX is to leverage salivary rinse samples to detect disease early and guide people to early…
Variant Bio is developing life-saving therapies by studying the genes of people with exceptional health-related traits.
Bullseye Biosciences is a therapeutics discovery company revolutionizing drug development through robotics and evolution. Our platform…
People
Stephen Dellaporta
Executive Officer, Director
Christopher Heffelfinger
Executive Officer
Mat Muller
Director
James Zhu
Director
Brian Staskawicz
Director
Kevin Lockett
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Cleveland AvenueVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
New Haven
United States
HQ
10-50 est. staff
How to cite this page
Alion, "Verinomics: key facts", as of Nov 13, 2026. https://alion.io/company/verinomics
These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0